United Health Products (UEEC) Return on Capital Employed (2011 - 2026)
United Health Products (UEEC) posted quarterly Return on Capital Employed of 26.4% for Q1 2026, down 16333.0% year-over-year from N/an in Q1 2025, and down 56.25% quarter-over-quarter from 60.34% in Q4 2025.
United Health Products (UEEC) Return on Capital Employed (2011 - 2026) Analysis & Trends
United Health Products (UEEC) has reported Return on Capital Employed for 16 consecutive years, with 26.4% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 16333.0% year-over-year to 26.4%; the TTM figure through Mar 2026 stood at 26.4% (down 16333.0% YoY), while the FY2025 annual figure was 61.8%, down 8540.0% from the prior year.
- Return on Capital Employed slipped to 26.4% in Q1 2026 per UEEC's latest filing, from 60.34% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 218.68% in Q3 2022 and bottomed at 26.4% in Q1 2026.
- Historically, Return on Capital Employed has averaged 134.76% across 5 years, with a median of 145.67% in 2023.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 8424466 bps — and 2025, when it jumped 8582 bps.
- United Health Products' Return on Capital Employed stood at 128.79% in 2022, then increased by 15 bps to 147.94% in 2023, then dropped by 5 bps to 140.31% in 2024, then slumped by 57 bps to 60.34% in 2025, then slumped by 56 bps to 26.4% in 2026.
- Business Quant data shows UEEC's Return on Capital Employed at 26.4% in Q1 2026, 60.34% in Q4 2025, and 144.71% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.68 Bn | 129.47 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.56 Bn | 51.70 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.77 Bn | 32.30 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.10 Bn | 26.42 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 3.28% |
| 10 | United Health Products | 9.79 Mn | 9.77 Mn | - | 23.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.40% |
| Dec 31, 2025 | 60.34% |
| Sep 30, 2025 | 144.71% |
| Jun 30, 2025 | 162.01% |
| Mar 31, 2025 | 189.73% |
| Dec 31, 2024 | 140.31% |
| Sep 30, 2024 | 79.50% |
| Jun 30, 2024 | 90.28% |
| Mar 31, 2024 | 103.91% |
| Dec 31, 2023 | 147.94% |
| Sep 30, 2023 | 150.96% |
| Jun 30, 2023 | 145.67% |
| Mar 31, 2023 | 148.57% |
| Dec 31, 2022 | 128.79% |
| Sep 30, 2022 | 218.68% |
| Jun 30, 2022 | 154.66% |
| Mar 31, 2022 | 198.53% |
| Dec 31, 2021 | 3,008.43% |
| Sep 30, 2021 | 3,545.47% |
| Jun 30, 2021 | 4,617.53% |